(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for monitoring ...

2020 has been quite a roller coaster ride for the stock markets. The recent positive developments regarding two COVID-19 vaccine candidates has been a drag on the work-from-home stocks but bodes well ...

Dexcom has launched its ONE+ continuous glucose monitoring (CGM) device in the UK, alongside a report that details high rates of anxiety and depression amongst type 2 diabetes (T2D) patients. The ...

When Kevin Sayer joined Dexcom in June 2011 after sitting on its board for four years, he found himself in a unusual situation. Nobody had ever held the president/COO role at the company, so ...

Dexcom is the leader in continuous glucose monitoring systems and the company has created a product that brings parents of children battling type 1 diabetes and users remarkable peace of mind. The San ...

Dexcom ($DXCM) won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other ...

DexCom, Inc. DXCM shares are trading higher in Thursday's after-hours session on the heels of the company's third-quarter earnings. Here's what happened. What To Know: DexCom reported earnings of 50 ...

With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry performed well in 2013 -- but which stocks were the biggest winners? Some of the best ...

2020 has been quite a roller coaster ride for the stock markets. The recent positive developments regarding two COVID-19 vaccine candidates has been a drag on the work-from-home stocks but bodes well ...